Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Geminii Health
AddedFeb 16, 2024
UpdatedJun 18, 2026
Geminii Health

Geminii Health

Seed

Geminii Health: Providing non-invasive diabetes treatment and therapy solutions.

HQ
Iowa City, IA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Geminii Health, founded with the mission to revolutionize diabetes care, focuses on providing non-invasive treatment and therapy solutions for diabetes patients. The company aims to improve the quality of life for individuals managing diabetes through innovative healthcare technologies. Their core offerings include advanced, non-invasive medical devices and therapeutic interventions designed to monitor and manage blood glucose levels effectively. Geminii Health targets a global market of diabetes patients seeking less intrusive and more comfortable treatment options.

Notable figures affiliated with Geminii Health include leading experts in endocrinology and medical device innovation. The company has attracted significant investment from venture capital firms specializing in healthcare technology. Key achievements include successful clinical trials demonstrating the efficacy of their non-invasive solutions and regulatory approvals that have paved the way for market entry. Geminii Health's impact is evident in its growing user base and positive patient outcomes, positioning it as a transformative player in the diabetes care industry.

Geminii Health - Quick Facts

When was Geminii Health founded?

Geminii Health was founded in 2016.

Where is Geminii Health's headquarters located?

Geminii Health's headquarters is located in Iowa City, IA, US.

When was Geminii Health's last funding round?

Geminii Health's most recent funding round was for $2.1M (USD) in September 2023.

How much has Geminii Health raised to-date?

As of Sep 1, 2023, Geminii Health has raised a total of $2.1M (USD).

How many employees does Geminii Health have?

Geminii Health has 7 employees as of Feb 4, 2024.

Geminii Health - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Telemedicine
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Diabetes Care
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities